Live
10x Genomics Blog10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets MojoAgilentMassachusetts Financial Services Co. MA Raises Stock Position in Agilent Technologies, Inc. $A - MarketBeatEndpoints NewsMore pharma dealmaking; FDA’s proposed budget; Takeda ends partnership; and moreThermo FisherIs It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo FinanceThermo FisherThermo Fisher expands global biobank leadership through collaboration with PRECISE-SG100K Singapore - BioSpectrum AsiaBioWorldSecond CRL for Replimune’s RP-1 for melanomaFierceBiotechFDA rejects Replimune’s melanoma prospect for second timeEndpoints NewsPlan for remade ACIP panel adds focus on vaccine safety, matching Kennedy’s pushEndpoints NewsBayer pharma executive predicts US-Europe price spreads will narrowBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-April 9, 2026Endpoints NewsFDA rejects Replimune cancer therapy, saying company didn't resolve trial doubts
10x Genomics Blog Apr 11, 2026

10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets Mojo

10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets Mojo

Original
Body unavailable. Use the original source.

Directory

59 All